查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1465998

血糖监测市场：按产品、测试技术、应用、分销管道和最终用户 - 全球预测 2024-2030

Blood Glucose Monitoring Market by Product, Testing Technology, Application, Distribution Channel, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年血糖监测市场规模为130.6亿美元，预计2024年将达到140.8亿美元，2030年将达228亿美元，复合年增长率为8.28%。

血糖监测是指追踪血液中血糖浓度的连续过程，这对于管理糖尿病的个人非常重要。这对于糖尿病患者来说极为重要。这种做法可以帮助您就饮食、运动和药物治疗做出明智的决定，有助于有效管理血糖值并降低糖尿病相关併发症的风险。糖尿病监测的使用增加主要是由于全球糖尿病盛行率不断上升、提供更简单和侵入性较小的监测方案的技术进步、对血糖控制重要性的认识提高以及综合护理模式的发展都是一个因素。 。然而，频繁的手指刺痛测试带来的不适和疼痛、监测用品的成本以及由于使用者错误或设备故障而导致读数不准确的可能性正在影响产品的采用。製造商专注于开发连续血糖监测仪 (CGM)，以减少用户参与，提供无痛即时监测，并且可以与行动技术整合以增强资料追踪和分析。血糖监测的未来机会非常丰富，包括非侵入性技术、用于预测分析的人工智慧 (AI) 以及有助于更个人化和高效的糖尿病管理的互连医疗设备。

主要市场统计
基准年[2023] 130.6亿美元
预测年份 [2024] 140.8亿美元
预测年份 [2030] 228亿美元
复合年增长率（%） 8.28%

提供产品自我血糖监测的个人化指导。

连续血糖监测仪非常适合需要即时血糖监测的患者，尤其是第 1 型糖尿病患者或需要强化胰岛素治疗的患者。 CGM 是为那些从全天追踪血糖浓度趋势中受益的用户开出的，可以实现更准确的胰岛素剂量和整体血糖管理。与自我监测血糖（SMBG）设备相比，CGM 的优点是不需要重复皮肤穿刺并提供连续、动态的血糖浓度测量。 CGM可以降低高血糖和低血糖的发生率，提高生活质量，改善血糖控制。自我血糖监测设备适用于不需要持续监测但确实想定期检查血糖值的人。它们适合第 1 型和第 2 型糖尿病患者，特别是那些透过饮食、运动、口服药物或偶尔注射胰岛素来控制病情的患者。 SMBG 设备提供测试时血糖值的简介，因此与更复杂的 CGM 相比，需要更少的承诺和费用。然而，SMBG 依赖穿刺测试，这可能因不舒适和不便而对某些使用者没有吸引力。

测试技术：电极式血糖仪开发为携带式和家用设备的潜力

电极血糖仪利用电化学反应来测量血液中的葡萄糖水平。将少量血液样本放在含有与葡萄糖反应的酵素的试纸上。此反应会产生小电流，由电极测量并在监视器上显示葡萄糖值。光电血糖仪应用光学测量原理，利用光来测量血液中的葡萄糖含量。光与试纸上的血液样本相互作用，吸收的光量指示葡萄糖浓度。电极监测器可实现快速且高精度的测量，使其适用于医疗和紧急情况以及需要仔细管理的糖尿病患者。另一方面，光电监视器提供了一种非侵入性的替代方案，迎合了那些寻求舒适度和降低潜在重复成本的人的需求。

应用 需要对第 1 型糖尿病进行准确和持续监测的先进 CGM

妊娠糖尿病（GDM）的特征是不同严重程度的葡萄糖耐受不良，通常在怀孕期间发生。 GDM 的血糖监测对于确保母亲和胎儿发育的健康至关重要。鑑于病情的暂时性，GDM 患者需要准确且易于使用的监测工具来有效管理其血糖浓度。 1 型糖尿病患者需要终身胰岛素治疗和定期血糖监测。 1 型糖尿病需要终身胰岛素治疗和定期血糖控制，而 GDM 则需要提供即时读数和趋势资讯的连续血糖监测系统 (CGM)。 2 型糖尿病通常与生活方式有关，需要个人血糖监测仪进行定期检查。患者可能更喜欢价格实惠且易于使用的血糖仪。具有连接性、允许储存资料以进行长期监测的血糖监测仪将吸引这一细分市场。妊娠糖尿病强调具有先进资料管理和共用功能的间歇性监测解决方案。相比之下，1 型糖尿病监测解决方案优先考虑准确性和持续监测。另一方面，2 型糖尿病市场注重成本效率和易用性，因为患者通常需要平衡糖尿病管理与生活的其他方面。

最终用户：提供血糖值监测仪，优化医院的临床效率和病患吞吐量。

居家照护主要涉及糖尿病患者或在非临床环境中有糖尿病风险的患者使用的血糖监测解决方案。在家庭护理领域，使用者通常喜欢结构紧凑、易于使用且需要最少维护的设备。智慧型手机连接和用于远端患者监护的无缝资料传输等功能正变得越来越受欢迎。准确性、可负担性和微创技术也是居家医疗使用者的偏好。医院和诊所是血糖监测的另一个主要领域，注重准确性、即时监测、与医院管理系统的集成，以及促进住院患者的全面护理。这些设施需要能够支援大量患者的设备，为电子健康记录(EHR) 整合提供强大的连接性，并确保准确、快速的测量，以便即时做出临床决策。优选高品质、可靠且易于消毒的设备，以防止交叉污染问题。

区域洞察

由于糖尿病盛行率不断上升，血糖监测设备在美洲已广泛应用，尤其是在糖尿病治疗市场成熟的美国。该地区系统生产的特点是高科技创新、严格的法律规范和大量的研发投资。美洲的主要企业提供先进的监测系统，包括连续血糖监测 (CGM) 设备和快速血糖监测系统。同时，在亚太地区（APAC），由于糖尿病人口的增加、医疗保健意识的提高以及医疗基础设施的改善，血糖监测市场正在快速增长，特别是在中国和印度等新兴经济体。亚太地区的生产变得更具成本效益且更容易获得，国际公司正在扩大其足迹，以满足不断增长的需求。虽然西欧以及美洲对创新、非侵入性监测技术的需求强劲，但中东和非洲是新兴市场，其成本限制和不同水准的卫生基础设施意味着基本的血糖监测系统受到重视。欧洲、中东和非洲地区的公司努力在引进先进产品和满足该地区不同地区的承受能力之间取得平衡。

FPNV定位矩阵

FPNV定位矩阵对于评估血糖监测市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对血糖监测市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，以获得市场竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1. 血糖监测市场的市场规模与预测是多少？

2.在血糖监测市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3. 血糖监测市场的技术趋势和法规结构是什么？

4.血糖监测市场主要厂商的市场占有率为何？

5.进入血糖监测市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 提高糖尿病盛行率和提高认识计划
      • 人们越来越青睐非侵入性血糖监测技术
      • 持续居家照护的需要
    • 抑制因素
      • 回顾血糖监测系统的负面影响
    • 机会
      • 血糖监测系统的设计与功能的进步
      • 加强血糖监测报销
    • 任务
      • 创建和操作血糖监测的复杂性
  • 市场区隔分析
    • 产品：提供自我血糖仪的个人指导
    • 测试技术：电极式血糖值监测仪被开发为携带式和家用设备的可能性
    • 应用：需要对第 1 型糖尿病进行精确连续监测的高级 CGM
    • 最终用户：提供血糖值监测仪以优化医院的临床效率和患者吞吐量
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章血糖监测市场：副产品

  • 连续血糖监测仪
  • 自我或一次性监测

第七章 血糖监测市场测试技术

  • 电极式血糖值仪
  • 光电血糖值仪

第八章血糖监测市场：依应用分类

  • 妊娠糖尿病
  • 1型糖尿病
  • 2型糖尿病

第九章血糖监测市场：依通路划分

  • 离线
  • 在线的

第10章血糖监测市场：依最终用户分类

  • 居家护理
  • 医院/诊所

第十一章美洲血糖监测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太血糖监测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲血糖监测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 雅培完成 Bigfoot Biomedical 的收购
    • Dexcom 推出新型穿戴式设备，无需胰岛素即可协助管理第 2 型糖尿病
    • Astellas来製药、Roche Diabetes Care Japan 和 Bluestar 签署合作协议，开发综合糖尿病自我管理解决方案并将其商业化
  • 战略分析和建议

第15章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-957C47F90031

[194 Pages Report] The Blood Glucose Monitoring Market size was estimated at USD 13.06 billion in 2023 and expected to reach USD 14.08 billion in 2024, at a CAGR 8.28% to reach USD 22.80 billion by 2030.

Blood glucose monitoring refers to the ongoing process of tracking the levels of glucose in the bloodstream, which is crucial for individuals managing diabetes. This practice helps in making informed decisions regarding diet, exercise, and medication, contributing to the effective management of blood sugar levels and reducing the risk of diabetes-related complications. The expansion of its use is primarily driven by the growing prevalence of diabetes globally, advancements in technology that provide more convenient and less invasive monitoring options, increased awareness about the importance of glycemic control, and the development of integrated care models. However, discomfort and pain related to frequent finger-prick tests, the cost of monitoring supplies, and the potential for inaccurate readings due to user error or device malfunction impact the product adoption. Manufacturers are focusing on developing continuous glucose monitors (CGMs) that offer painless, real-time monitoring while reducing user involvement, as well as investing in smart devices that can integrate with mobile technology for enhanced data tracking and analysis. The future opportunities in blood glucose monitoring are abundant, with prospects of non-invasive techniques, artificial intelligence (AI) for predictive analytics, and interconnected healthcare devices that could contribute to a more personalized and efficient diabetes management landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 13.06 billion
Estimated Year [2024] USD 14.08 billion
Forecast Year [2030] USD 22.80 billion
CAGR (%) 8.28%

Product: Provision of personalized guidance in self-monitoring blood glucose monitors

Continuous blood glucose monitors are ideal for patients who require real-time glucose monitoring, particularly those with Type 1 diabetes or those who have intensive insulin therapy needs. CGMs are prescribed for users who benefit from tracking trends in glucose levels throughout the day, enabling more precise insulin dosing and better overall glucose management. Compared to self-monitoring blood glucose (SMBG) devices, CGMs offer the advantage of providing continuous, dynamic glucose level readings without the need for repeated skin punctures. They can reduce the incidence of both hyperglycemia and hypoglycemia, enhance quality of life, and improve glycemic control. Self-monitoring blood glucose devices are used by individuals who may not need continuous monitoring but still require regular checks of their glucose levels. These are suited for patients with both Type 1 and Type 2 diabetes, particularly those who manage their condition through diet, exercise, oral medication, or occasional insulin injections. SMBG devices provide a snapshot of the glucose level at the time of testing, requiring less commitment and expense compared to the more sophisticated CGMs. However, SMBGs rely on puncture tests, which can be less appealing to some users due to discomfort or inconvenience.

Testing Technology: Potential of electrode-type blood glucose monitors to be developed as portable and home-use devices

Electrode-type blood glucose monitors function by utilizing electrochemical reactions to measure glucose levels in the blood. A small blood sample is placed on a test strip, which contains an enzyme that reacts with glucose. The reaction produces a small electrical current that is measured by the electrodes, and the glucose level is then displayed on the monitor. Photoelectric blood glucose monitors work on the principle of photometry and uses a beam of light to measure the amount of glucose in the blood. The light interacts with the blood sample on the test strip, and the amount of light absorbed indicates the glucose concentration. Electrode-type monitors offer quick and highly accurate measurements, which makes them suitable for medical and emergency settings, as well as for diabetic patients who closely manage their condition. On the other hand, photoelectric monitors provide a non-invasive alternative that caters to those who seek comfort and potentially lower repetitive costs.

Application: Need for sophisticated CGMs with accuracy and constant monitoring for type-1 diabetes

Gestational diabetes mellitus (GDM) is characterized by glucose intolerance of varying severity and typically occurs during pregnancy. Blood glucose monitoring for GDM is critical to ensure the health of the mother and the developing fetus. Patients with GDM may have a specific need for monitoring tools with high accuracy and ease of use to manage glucose levels effectively, considering the temporary phase of their condition. Individuals with Type 1 Diabetes require lifelong insulin therapy and regular blood glucose monitoring. GDM requires continuous glucose monitoring systems (CGMs) that provide real-time readings and trend information, which can help in the tight management of their condition. Type 2 Diabetes, often related to lifestyle factors, requires personal blood glucose monitors for regular checks. Patients might prefer affordable and simple-to-use glucometers. Blood glucose monitors with connectivity features that can store data for long-term observation appeal to this segment. For gestational diabetes, the market emphasizes temporary monitoring solutions with advanced data management and sharing capabilities. In contrast, Type 1 Diabetes monitoring solutions prioritize accuracy and constant monitoring. Meanwhile, the market for Type 2 Diabetes focuses on cost-efficiency and ease of use, as patients often need to balance diabetes management with other life commitments.

End-User: Provision of blood glucose monitors that optimize clinical efficiency and patient throughput in hospitals

Home care pertains to blood glucose monitoring solutions used by individuals with diabetes or at risk of developing diabetes, primarily in a non-clinical setting. In the home care segment, users typically prefer compact, easy-to-use devices with minimal maintenance. Features such as connectivity to smartphones and seamless data transfer for remote patient monitoring are increasingly popular. Accuracy, affordability, and minimally invasive technology are also high on the preference list for home care users. Hospitals and clinics represent another major segment for blood glucose monitoring, where the emphasis is on precision, real-time monitoring, integration with hospital management systems, and the facilitation of comprehensive care for inpatients. These establishments require devices that can support a high volume of patients, offer robust connectivity for electronic health records (EHR) integration, and ensure precise, quick readings to inform immediate clinical decisions. High-quality, reliable, and easily sterilizable devices are preferred to prevent cross-contamination issues.

Regional Insights

In the Americas, blood glucose monitoring devices are widely used, owing to the increasing prevalence of diabetes, particularly in the United States, which has a mature market for diabetes care. The production of these systems in this region is characterized by high technological innovation, stringent regulatory oversight, and substantial investments in research and development. Major companies based in the Americas provide advanced monitoring systems, including continuous glucose monitoring (CGM) devices and flash glucose monitoring systems. On the other hand, in the Asia-Pacific (APAC) region, there is rapid growth in the blood glucose monitoring market, fueled by the rising diabetic population, growing healthcare awareness, and improving healthcare infrastructure, particularly in emerging economies such as China and India. Production in APAC tends to focus on cost-effectiveness and accessibility, with international companies expanding their footprint to capture the burgeoning demand. Western Europe shows a strong demand for innovative and non-invasive monitoring technologies similar to the Americas, while the Middle East and Africa are emerging markets with a focus on basic glucose monitoring systems due to cost constraints and varying levels of healthcare infrastructure. Companies in the EMEA region are working to strive to balance between introducing advanced products and catering to affordability in different parts of the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Blood Glucose Monitoring Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood Glucose Monitoring Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Blood Glucose Monitoring Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AdvaCare Pharma, Advin Health Care, ARKRAY, Inc., Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation, B. Braun Melsungen AG, BAYER AG, Becton, Dickinson and Company, Dexcom, Inc., F. Hoffmann-La Roche Ltd., GlySens Incorporated, I-SENS, Inc., Insulet Corporation, Johnson & Johnson Services, Inc., LifeScan IP Holding, LLC., Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Nipro Europe Group Companies, Nova Biomedical, Novo Nordisk A/s, NXP Semiconductors N.V., PHC Holding Corporation, Prodigy Diabetes Care LLC, Sanofi S.A., Senseonics Holdings Inc., Sinocare Inc., Teladoc Health, Inc., Terumo Corporation, and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Blood Glucose Monitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Continuous Blood Glucose Monitors
      • Insulin Pumps
      • Sensors
      • Transmitter & Receiver
    • Self or One Time Monitors
      • Blood Glucose Meter
      • Lancets
      • Testing Strips
  • Testing Technology
    • Electrode Type Blood Glucose Monitor
    • Photoelectric Blood Glucose Monitor
  • Application
    • Gestational Diabetes
    • Type 1 Diabetes
    • Type 2 Diabetes
  • Distribution Channel
    • Offline
    • Online
  • End-User
    • Home Care
    • Hospital & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Blood Glucose Monitoring Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood Glucose Monitoring Market?

3. What are the technology trends and regulatory frameworks in the Blood Glucose Monitoring Market?

4. What is the market share of the leading vendors in the Blood Glucose Monitoring Market?

5. Which modes and strategic moves are suitable for entering the Blood Glucose Monitoring Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of diabetes and improved awareness programs
      • 5.1.1.2. Increasing preference for non-invasive blood glucose monitoring technology
      • 5.1.1.3. Need for continuous blood glucose monitoring in-home care settings
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse recalls of blood glucose monitoring systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in design and capabilities of blood glucose monitoring systems
      • 5.1.3.2. Enhancements in the reimbursements for blood glucose monitoring
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity in the production and operation of blood glucose monitoring
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Provision of personalized guidance in self-monitoring blood glucose monitors
    • 5.2.2. Testing Technology: Potential of electrode-type blood glucose monitors to be developed as portable and home-use devices
    • 5.2.3. Application: Need for sophisticated CGMs with accuracy and constant monitoring for type-1 diabetes
    • 5.2.4. End-User: Provision of blood glucose monitors that optimize clinical efficiency and patient throughput in hospitals
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Blood Glucose Monitoring Market, by Product

  • 6.1. Introduction
  • 6.2. Continuous Blood Glucose Monitors
  • 6.3. Self or One Time Monitors

7. Blood Glucose Monitoring Market, by Testing Technology

  • 7.1. Introduction
  • 7.2. Electrode Type Blood Glucose Monitor
  • 7.3. Photoelectric Blood Glucose Monitor

8. Blood Glucose Monitoring Market, by Application

  • 8.1. Introduction
  • 8.2. Gestational Diabetes
  • 8.3. Type 1 Diabetes
  • 8.4. Type 2 Diabetes

9. Blood Glucose Monitoring Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Blood Glucose Monitoring Market, by End-User

  • 10.1. Introduction
  • 10.2. Home Care
  • 10.3. Hospital & Clinics

11. Americas Blood Glucose Monitoring Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Blood Glucose Monitoring Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Blood Glucose Monitoring Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Abbott Completes Acquisition Of Bigfoot Biomedical
    • 14.3.2. Dexcom Announces Novel Wearable For Managing Type 2 Diabetes - Without Insulin
    • 14.3.3. Astellas and Roche Diabetes Care Japan Ink Partnership Agreement To Develop And Commercialize Integrated Diabetes Self-Management Solution with BlueStar
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BLOOD GLUCOSE MONITORING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD GLUCOSE MONITORING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BLOOD GLUCOSE MONITORING MARKET DYNAMICS
  • FIGURE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. BLOOD GLUCOSE MONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. BLOOD GLUCOSE MONITORING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD GLUCOSE MONITORING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SENSORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SENSORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TRANSMITTER & RECEIVER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TRANSMITTER & RECEIVER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY BLOOD GLUCOSE METER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY BLOOD GLUCOSE METER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY LANCETS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY LANCETS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING STRIPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING STRIPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ELECTRODE TYPE BLOOD GLUCOSE MONITOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ELECTRODE TYPE BLOOD GLUCOSE MONITOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PHOTOELECTRIC BLOOD GLUCOSE MONITOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PHOTOELECTRIC BLOOD GLUCOSE MONITOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY OFFLINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ONLINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ONLINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOME CARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 111. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 124. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 125. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 135. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 138. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 139. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 142. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 162. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 164. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 165. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 166. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 167. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 170. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 174. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 175. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 176. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 177. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 178. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 179. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 180. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 181. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 184. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 185. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 190. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 191. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 192. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 193. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 194. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 195. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 198. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 199. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 202. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 203. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 204. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 205. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 206. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 207. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 208. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 209. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 212. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 213. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 214. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 215. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 216. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 217. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 218. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 219. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 220. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 221. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 222. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 223. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 226. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 227. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 230. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 231. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 232. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 233. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 234. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 235. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 236. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 237. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 238. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 239. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 240. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 241. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 244. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 245. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 246. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 247. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 248. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 249. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 250. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 251. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 254. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 255. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 258. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 259. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 260. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 261. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 262. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 263. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 264. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 265. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 268. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 269. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 272. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 273. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 274. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 275. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 276. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 277. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 278. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 279. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 282. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 283. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 288. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 289. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 290. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 291. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 292. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 293. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 294. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 295. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 296. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 297. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 298. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 299. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 300. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 301. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
  • TABLE 302. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
  • TABLE 303. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
  • TABLE 304. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
  • TABLE 305. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 306. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 307. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 310. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 311. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 312. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 313. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 314. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)